Videos

Edward Chu, MD, MMS, discusses the impact of the phase 3 MK-3475-177/KEYNOTE-177 trial in ​metastatic colorectal cancer.

Dr. Chu on the Impact of the KEYNOTE-177 Trial in mCRC 

Articles

Early in the pandemic, the Montefiore hospital leadership had the forethought and insight to create a reliable and robust outcomes data collection system on all patients with a diagnosis of COVID-19 being seen and treated within the system.

A View From the Frontlines: How a Hospital System Coped With a COVID-19 Peak

The prominent physician-scientist will also be appointed professor of medicine and molecular pharmacology at Einstein



Edward Chu, MD, MMS, To Lead Cancer Medicine at Albert Einstein College of Medicine and Montefiore Health System

Investigators at Montefiore showed that axicabtagene-ciloleucel can be used successfully in ethnically diverse patients with high-risk, relapsed/refractory diffuse large B-cell lymphoma at an inner-city hospital.

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting

Balazs Halmos, MD, MS, provides insight on preventive measures put in place at his institution, day-to-day challenges faced in practice, and how he is staying connected with the broader community to share information.

Keeping Up With COVID-19: Adaptability Is the Strongest Weapon in the Arsenal

Balazs Halmos, MD, MS, provides insight into how his institution continues to adapt in response to the COVID-19 crisis.

Montefiore Einstein Center for Cancer Care

Latest from Montefiore Einstein Center for Cancer Care

New content coming soon, please check back later.